NCT00657241View on ClinicalTrials.gov

Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Hypertension
Interventions
DRUG

Carvedilol CR

DRUG

Valsartan

Trial Locations (1)

14215

Erie County Medical Center, Buffalo

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

State University of New York at Buffalo

OTHER